These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

768 related items for PubMed ID: 9286575

  • 1. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M, Taddei C, Nguyen JM, Dantal J, Hourmant M, Cantarovich D, Blancho G, Ancelet D, Soulillou JP.
    Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
    [Abstract] [Full Text] [Related]

  • 2. Annual trends and triple therapy--1991-2000.
    Nishikawa K, Terasaki PI.
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [Abstract] [Full Text] [Related]

  • 3. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A, Woo KT.
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [Abstract] [Full Text] [Related]

  • 4. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A.
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [Abstract] [Full Text] [Related]

  • 5. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW.
    Clin Transpl; 2002; ():335-49. PubMed ID: 12971460
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Kidney transplantation, the Halifax experience.
    Belitsky P, MacDonald AS, Lawen J, McAlister V, Bitter-Suermann H, Kiberd B, West K, Sketris I.
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [Abstract] [Full Text] [Related]

  • 8. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM.
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [Abstract] [Full Text] [Related]

  • 9. Immunosuppression in live-related donor renal transplantation.
    Iman A, Rao M, Juneja R, Jacob CK.
    Natl Med J India; 2001 Jun; 14(2):75-80. PubMed ID: 11396322
    [Abstract] [Full Text] [Related]

  • 10. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T, Kapischke M, Busing M.
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [Abstract] [Full Text] [Related]

  • 11. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R, Yagmurdur MC, Karakayali F, Haberal C, Ozcelik U, Colak T, Haberal M.
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [Abstract] [Full Text] [Related]

  • 12. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 13. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 14. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 15. An analysis of predictors of long-term cadaveric renal allograft survival.
    Cole E, Naimark D, Aprile M, Wade J, Cattran D, Pei Y, Fenton S, Robinette M, Zaltsman J, Bear R.
    Clin Transplant; 1995 Aug; 9(4):282-8. PubMed ID: 7579734
    [Abstract] [Full Text] [Related]

  • 16. Long-term results of a prospective randomized study comparing two immunosuppressive regimens, one with and one without CsA, in low-risk renal transplant recipients.
    Grimbert P, Baron C, Fruchaud G, Hemery F, Desvaux D, Buisson C, Chopin D, Dahmane D, Remy P, Pastural M, Abbou C, Weil B, Lang P.
    Transpl Int; 2002 Nov; 15(11):550-5. PubMed ID: 12461659
    [Abstract] [Full Text] [Related]

  • 17. One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients.
    Wang D, Chen JH, Wu WZ, Yang SL, Wu GJ, Wang H, Tan JM.
    Transplant Proc; 2007 Nov; 39(1):69-72. PubMed ID: 17275476
    [Abstract] [Full Text] [Related]

  • 18. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D.
    J Nephrol; 2004 Nov; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [Abstract] [Full Text] [Related]

  • 19. Independent risk factors predicting acute graft rejection in cardiac transplant recipients treated by triple drug immunosuppression.
    Laufer G, Miholic J, Laczkovics A, Wollenek G, Holzinger C, Hajek-Rosenmeier A, Wuzl G, Schreiner W, Buxbaum P, Wolner E.
    J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1113-21. PubMed ID: 2586129
    [Abstract] [Full Text] [Related]

  • 20. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.
    MacDonell RC, Van Buren DH, Richie RE, Johnson HK, Nylander WA, Helderman JH, Ynares CM, Trusler LA, Green WF, Crowe DA.
    Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.